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Oncogenesis induced by insertional mutagenesis with
gene therapy vectors occurs mainly by activation of
proto-oncogenes found at or nearby the insertion site.
This activation often occurs by an enhancer-mediated
mechanism or by a process of splicing capture which
generates chimeric transcripts comprising portions of
vector and cellular mRNAs. Although the activation of
oncogenes may be reduced by the use of self-inactivat-
ing design and moderate cellular promoters, how to
reduce genotoxic splicing capture events and aberrant
transcript formation triggered by vector integration is
still unclear.
We developed a modified Linear Amplification-
Mediated (LAM) PCR technique, named cDNA LAM
PCR (cLAM-PCR), aimed at retrieving, from the whole
transcriptome of LV-transduced cells aberrantly spliced
mRNAs that contain lentiviral vector (LV) sequences
fused with cellular transcripts in a high-throughput fash-
ion. The sequences of cLAM-PCR products were
obtained by 454 pyrosequencing and analyzed by dedi-
cated high-throughput computational pipeline running
in a computer cluster that use a dynamic analysis pro-
cess composed by different steps based on a map-reduce
parallelization model. Thus, chimeric LV-genome
sequences are recognized, the nucleotide position of the
fused sequence is identified (the splice site), and the
remaining portion mapped on the appropriate genome
assembly by BLAST.
We identified several established and previously
unknown splice sites within the LV backbone that parti-
cipate in the aberrant splicing process with variable effi-
ciency. Results obtained with different LV designs show
that integrated LVs can perturb the processing of cellu-
lar transcripts by interacting with the cellular splicing
machinery and fusing with its own splice sites to cellular
splice sites both upstream and downstream the integra-
tion site. So far, 70 different fusion transcripts could be
identified in total, 84% of which were fused to known
splice sites of gene exons, 6% were fused to uncharacter-
ized cryptic splice sites located in introns and the
remaining 10% were fused to genomic sequences not
corresponding to any annotated gene. This analysis
allows identifying also several different slice sites within
the LV backbone that participated to the aberrabt spli-
cing process. Quantitative PCR on different LV portions
within the LV backbone allow measuring the relative
contribution to the aberrant splicing process of each
splice site identified. Interestingly, the amount of tran-
scription occurring in regions outside the expression
cassette reaches the 3% of the entire transgene
expression.
The cLAM-PCR technique, coupled to high-through-
put sequencing and the computational power of our
specialized data analysis pipeline allows gaining
insights into the biology of vector-mediated splicing
alteration. Since this process could induce neoplastic
transformation by the generation of aberrant oncogenic
protein, its in-depth characterization is instrumental in
the development of next-generation LV with a higher
safety profile.
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